April 2014
Volume 55, Issue 13
ARVO Annual Meeting Abstract  |   April 2014
Peptidoglycan recognition protein 2 (Pglyrp 2) exacerbates Pseudomonas aeruginosa keratitis in a mouse model.
Author Affiliations & Notes
  • Shukti Chakravarti
    Medicine, Johns Hopkins Medical Institution, Baltimore, MD
    Ophthalmology, Johns Hopkins Medical Institution, Baltimore, MD
  • Ranjita N Gowda
    Medicine, Johns Hopkins Medical Institution, Baltimore, MD
  • Sudarshan Punglay
    Medicine, Johns Hopkins Medical Institution, Baltimore, MD
  • Wai-Hong Wu
    Medicine, Johns Hopkins Medical Institution, Baltimore, MD
  • Abdel R Hamad
    Pathology, Johns Hopkins Sch of Medicine, Baltimore, MD
  • Footnotes
    Commercial Relationships Shukti Chakravarti, None; Ranjita Gowda, None; Sudarshan Punglay, None; Wai-Hong Wu, None; Abdel Hamad, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 1463. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Shukti Chakravarti, Ranjita N Gowda, Sudarshan Punglay, Wai-Hong Wu, Abdel R Hamad; Peptidoglycan recognition protein 2 (Pglyrp 2) exacerbates Pseudomonas aeruginosa keratitis in a mouse model.. Invest. Ophthalmol. Vis. Sci. 2014;55(13):1463.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: Others and we detected four mammalian peptidoglycan recognition proteins, Pglyrp1-4, in the human and mouse cornea. We reported earlier that Pglyrp1-/- mice were more susceptible to Pseudomonas aeruginosa keratitis, indicating a protective role for this antimicrobial protein. Here we investigated P. aeruginosa keratitis in Pglyrp 2-/-, Pglyrp 3-/-, Pglyrp 4-/- and wild type Balb/c (WT) mice to determine the role of Pglyrp2-4 in ocular surface defense.

Methods: One eye each, in 6-8 week old mice were scarified and infected with approximately 50,000 cfu P. aeruginosa (ATCC19660). Both males and females (n=6-9 per genotype), gender matched within an experiment were used. Five independent keratitis experiments/genotype were conducted. Visual disease scores were given in a blinded manner 1 and 2 days post infection. Viable bacterial counts and IL-12, TNF-α, IFN-γ, CCL2, IL-6 and IL-10 levels (Cytometric Bead Array, BD Biosciences) were measured in whole eye homogenates. Expression of Pglyrp1-4 was determined by qRTPCR from total RNA extracts of uninfected and infected eyes of WT and Pglyrp null mice.

Results: The Pglyrp 2-/- mice, males in particular, showed consistently lower disease scores and bacterial yield compared to WT (p= 0.02 and p= 0.004 for disease score and CFU, respectively). The Pglyrp 4-/- mice also manifested reduced disease score and bacterial load without reaching statistical significance. Induction of TNF-α in infected Pglyrp 2-/- eyes was lower than that of WT mice. The Pglyrp 3-/- mice showed no significant differences in disease scores, bacterial yield or induction of cytokines compared to WT, and expression of Pglyrp4 was elevated. Pglyrp1 expression was constitutively high in the WT and Pglyrp2-4 null mouse eyes, while Pglyrp2 was induced in WT infected eyes.

Conclusions: In addition to being an amidase that hydrolyses peptidoglycans, Pglyrp2 is known to promote pro-inflammatory signals. Our results indicate that Pglyrp2 may be counter-productive to clearing Pseudomonas infections, and its expression tightly regulated during infections and inflammation.

Keywords: 573 keratitis • 555 immunomodulation/immunoregulation • 433 bacterial disease  

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.